These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31475061)

  • 21. Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power-Injectable Totally Implanted Venous Access Devices among Cancer Patients.
    Burbridge B; Plewes C; Stoneham G; Szkup P; Otani R; Babyn P; Bryce R
    J Vasc Interv Radiol; 2018 May; 29(5):648-656.e3. PubMed ID: 29499999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port Catheters.
    Tippit D; Siegel E; Ochoa D; Pennisi A; Hill E; Merrill A; Rowe M; Henry-Tillman R; Ananthula A; Makhoul I
    Breast Cancer (Auckl); 2018; 12():1178223418771909. PubMed ID: 29881287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.
    Liberale G; El Houkayem M; Viste C; Bouazza F; Moreau M; El Nakadi I; Veys I
    Support Care Cancer; 2016 Dec; 24(12):5035-5040. PubMed ID: 27495928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Totally implantable venous access devices - 20 years' experience of implantation in cystic fibrosis patients.
    Royle TJ; Davies RE; Gannon MX
    Ann R Coll Surg Engl; 2008 Nov; 90(8):679-84. PubMed ID: 18990281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.
    Lin WY; Lin CP; Hsu CH; Lee YH; Lin YT; Hsu MC; Shao YY
    Br J Cancer; 2017 Sep; 117(7):932-937. PubMed ID: 28787431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for totally implantable venous access device-associated complications in cystic fibrosis.
    McCarthy C; O'Carroll O; O'Brien ME; McEnery T; Franciosi A; Gunaratnam C; McElvaney NG
    Ir J Med Sci; 2018 May; 187(2):429-434. PubMed ID: 28812224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable.
    Sun X; Zhang Y; Yang C; Zhou Y; Bai X; Zheng W; Jin Y
    Geriatr Gerontol Int; 2019 Mar; 19(3):218-221. PubMed ID: 30724007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of chemotherapy type and timing among the other factors on patency of totally implantable vascular access devices in colorectal carcinoma.
    Aribas BK; Yildiz F; Uylar T; Tiken R; Aydin H; Akdulum I; Seber T; Caglar E; Savran B; Aribas O
    J Vasc Access; 2021 Nov; ():11297298211059263. PubMed ID: 34796758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period.
    Kariyawasam HH; Pepper JR; Hodson ME; Geddes DM
    Respir Med; 2000 Dec; 94(12):1161-5. PubMed ID: 11192950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expert consensus on the clinical application of totally implantable venous access devices in the upper arm (2022 Edition).
    Qiu X; Jin G; Zhang X; Xu L; Ding J; Li W; Yu L; Wang Y; Shen Y; Wang H; Wang J; Xu H; Kong W; Yuan L; Bai X; Liu Y; Liu H; Cai M; Luo F; Yang Y; Xiao W; Shen L; Fang Y; Lin J; Zhao L; Qin L; Gao Y; Chang L; Dong L; Wei H; Wei L
    J Interv Med; 2023 May; 6(2):53-58. PubMed ID: 37409058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement.
    Song MG; Seo TS; Kim YH; Cho SB; Chung HH; Lee SH; Jung E
    J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cephalic vein access for implantable venous access devices. Technique and long-term follow-up].
    Conessa C; Talfer S; Herve S; Chollet O; Poncet JL
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(3):143-8. PubMed ID: 12577777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complications with totally implantable venous access device. A retrospective of 116 cases].
    Talfer S; Conessa C; Hervé S; Roguet E; de Rotalier P; Poncet JL
    Presse Med; 2003 Aug; 32(27):1263-8. PubMed ID: 14506448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Totally implantable venous access devices via subclavian vein: a retrospective study of 368 oncology patients.
    Ozyuvaci E; Kutlu F
    Adv Ther; 2006; 23(4):574-81. PubMed ID: 17050500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
    Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
    Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
    Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
    Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.